
Serum magnesium, bone–mineral metabolism markers and their interactions with kidney function on subsequent risk of peripheral artery disease: the Atherosclerosis Risk in Communities Study
Author(s) -
Steven Menez,
Ning Ding,
Morgan E. Grams,
Pamela L. Lutsey,
Gerardo Heiss,
Aaron R. Folsom,
Elizabeth Selvin,
Josef Coresh,
Bernard G. Jaar,
Kunihiro Matsushita
Publication year - 2020
Publication title -
nephrology, dialysis, transplantation/nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfaa029
Subject(s) - medicine , hazard ratio , renal function , endocrinology , fibroblast growth factor 23 , proportional hazards model , kidney disease , confounding , quartile , risk factor , parathyroid hormone , calcium , confidence interval
Few studies have investigated the association of magnesium levels with incident peripheral artery disease (PAD) despite emerging evidence of magnesium contributing to vascular calcification. Moreover, no data are available on whether the magnesium-PAD relationship is independent of or modified by kidney function.